DHP agonists directly activate cardiac ryanodine receptors, potentially explaining their negative inotropic effects via sarcoplasmic reticulum calcium loss.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for DHP agonist effects on cardiac RyR; should not yet alter clinical calcium channel blocker use.
Sagawa et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: